Ktl-Plus Eye Drops contain a combination of Ofloxacin 0.3% w/v, a broad-spectrum fluoroquinolone antibiotic, and Ketorolac 0.5% w/v, a nonsteroidal anti-inflammatory drug (NSAID). This dual-action formulation is indicated for the treatment of bacterial ocular infections accompanied by inflammation and pain. Ofloxacin acts by inhibiting bacterial DNA gyrase and topoisomerase IV, thereby preventing bacterial replication and effectively eradicating susceptible pathogens. Ketorolac provides potent anti-inflammatory and analgesic effects by inhibiting cyclooxygenase enzymes (COX-1 and COX-2), reducing the synthesis of prostaglandins responsible for inflammation, pain, and edema. Ktl-Plus Eye Drops are primarily used in conditions such as bacterial conjunctivitis, keratitis, and postoperative ocular inflammation where both infection control and inflammation management are required. The combination ensures rapid symptomatic relief while addressing the underlying infection. The formulation is intended for topical ocular administration, with dosing typically prescribed by an ophthalmologist based on the severity of the condition. Patients should avoid contact lens use during treatment and adhere strictly to the recommended dosage to minimize potential adverse effects such as ocular irritation, burning sensation, or hypersensitivity reactions. Ktl-Plus Eye Drops should be used with caution in patients with known hypersensitivity to fluoroquinolones or NSAIDs.